Document is current
Any future updates will be listed below
-
Authors
Kovačič, Tristan
Haas, Heinrich https://orcid.org/0000-0002-5517-5970
Stotsky-Oterin, Lior
Štrancar, Aleš
Bren, Urban https://orcid.org/0000-0002-8806-3019
Peer, Dan https://orcid.org/0000-0001-8238-0673
- License Information
-
More Information
Article History
Accepted: 8 September 2025
First Online: 8 October 2025
Competing interests
: D.P. receives licensing fees (to patents of which he was an inventor) from, is invested in, consults (or sits on scientific advisory boards or boards of directors) or Founder and hold shares or conducts sponsored research at Tel Aviv University for the following entities: ART Biosciences, BioNTech SE, Earli Inc., Kernal Biologics Inc., LAND Medicine Inc., Merck KGaA, Newphase Ltd., NeoVac Ltd., RiboX Therapeutics, Roche, SirTLabs Corporation, and Teva Pharmaceuticals Inc. T.K. and A.Š. are employees of Sartorius BIA Separations d.o.o. A.Š. hold shares in Sartorius Stedim Biotech and Mediainvest. H.H. is an employee of NeoVac Ltd. and holds shares in the company. All other authors declare no competing interests.
